ATR inhibition promotes IFN signaling via G2 checkpoint abrogation in irradiated human cancer cells
Adrian Eek Mariampillai,
Norway
OC-0261
Abstract
ATR inhibition promotes IFN signaling via G2 checkpoint abrogation in irradiated human cancer cells
Authors: Adrian Eek Mariampillai1, Sissel Hauge1, Inger Øynebråten2, Gro Elise Rødland1, Alexandre Corthay2,3, Randi G. Syljuåsen1
1Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Dept. Radiation Biology, Oslo, Norway; 2Rikshospitalet, Oslo University Hospital, Dept. Pathology, Oslo, Norway; 3Institute for Basic Medical Sciences, University of Oslo, Hybrid Technology Hub - Centre of Excellence, Oslo, Norway
Show Affiliations
Hide Affiliations
Purpose or Objective
The
serine/threonine protein kinase ATR is a central regulator of the G2 cell cycle
checkpoint and homologous recombination repair after irradiation. When ATR
inhibitors are combined with irradiation, cancer cells will enter mitosis with
unrepaired DNA lesions, resulting in micronucleus formation and cell death. Interestingly,
recent studies suggest that ATR inhibitors, besides their effects on cell cycle
checkpoints and DNA repair, may also increase radiation-induced antitumor
immune responses. Yet, the underlying mechanisms and their impact in human
cancers remain scarcely understood. Notably, the DNA sensing protein cyclic
GMP-AMP synthase (cGAS) can bind to cytosolic DNA from ruptured micronuclei, thereby
promoting type I interferon (IFN) gene expression. We aimed to assess whether
ATR inhibitors, by abrogating the G2 checkpoint, increase cGAS-mediated IFN signaling
after irradiation of human cancers.
Material and Methods
The
human lung cancer cell lines SW900, H1975, A549 and H460 and osteosarcoma cell
line U2OS were treated with radiation (2-20 Gy) and two different ATR
inhibitors (VE822 at 50/250 nM; AZD6738 at 250/1250 nM). Cell cycle checkpoint
abrogation was assayed by flow cytometry. IFN signaling following cGAS-detected
cytosolic DNA was measured by phospho-STAT1 immunoblotting and IFN-β ELISA. cGAS
depletion was achieved by siRNA transfection, and cGAS localization was
assessed through immunofluorescence microscopy. Levels of the exonuclease TREX1
were measured by immunoblotting.
Results
Supporting
that the G2 checkpoint prevents IFN induction, we observed a reduction of
radiation-induced increase in phospho-STAT1 levels after high radiation doses,
correlating with prolonged G2 checkpoint arrest. In contrast, we found no
radiation-induced increase in TREX1 levels previously reported to correlate
with reduced IFN responses at high radiation doses. Co-treatment with radiation
(5 Gy) and ATR inhibitors abrogated the G2 checkpoint in all cell lines, accompanied
by increased radiation-induced IFN signaling in U2OS, SW900 and A549, and
weakly in H1975. Checkpoint abrogation and IFN signaling similarly depended on
ATR inhibitor concentration. cGAS co-localized with micronuclei, and depletion
of cGAS abolished IFN responses, indicating its dependency on cGAS-detection of
cytosolic DNA from ruptured micronuclei in these cell lines. Contrastingly, H460
cells showed no increase in IFN signaling or detectable cGAS foci. H460 presented
higher baseline levels of TREX1 than the other cell lines, suggesting TREX1 to
prevent cGAS signaling in H460.
Conclusion
Co-treatment
with irradiation and ATR inhibition can increase cGAS-dependent IFN signaling
in some, but not all, cancer cell lines. High baseline TREX1 expression warrants further consideration as a possible predictive
marker for lack of IFN signaling.